Cite Filings / ARWR / 0001628280-25-002848

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ARROWHEAD PHARMACEUTICALS, INC. Filed 2025-01-29 Acc 0001628280-25-002848

Documents 1

DEF 14A Proxy Statement , arwr-20250128.htm

Around this filing

2026-01-27 DEF 14A Proxy Statement
2025-01-29 ARS Annual Report to Security Holders
2025-01-29 DEFA14A Proxy Materials
2025-01-29 DEF 14A Proxy Statement
2025-01-27 4 Director sold 959 shares at $21.00 ($20,139)
2025-01-23 144 Sale of Securities
2024-01-26 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading arwr-20250128.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…